{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001214","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2025-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.844523+00:00","generated_at":"2026-05-28T09:39:35.134546+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aspira Women's Health interim CFO John Kallassy resigns; CEO becomes principal accounting officer","bullets":["John Kallassy resigned as Interim CFO effective January 10, 2025, for personal reasons.","CEO Dr. Sandra Milligan will serve as principal accounting officer until a permanent CFO is appointed.","Board reinstated Dr. Milligan's full salary retroactive to December 16, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001214","json":"https://secwatch.observer/filing/0001493152-25-001214.json","markdown":"https://secwatch.observer/filing/0001493152-25-001214.md","text":"https://secwatch.observer/filing/0001493152-25-001214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T09:39:35.134546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93c63526bd","claim":"Sandra Milligan was appointed as principal accounting officer at Aspira Women's Health Inc..","evidence_excerpt":"The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed as principal accounting officer"},{"label":"Role","value":"principal accounting officer"}]},{"claim_id":"ae92db0441","claim":"John Kallassy resigned as Interim Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Interim Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}